AXA Investment Managers, an investment management company, agreed to acquire Kadans Science Partner, a company that focuses on the development and operation of inspiring commercial and office buildings, from Oaktree Capital Management for $590m. “For many years Kadans has accommodated knowledge-intensive enterprises throughout Europe, based upon our strong belief that the expansion of knowledge is an important driver of economic growth in Europe. The ecosystems we develop therefore aim to facilitate collaboration and knowledge sharing. We are grateful to Oaktree for the support over the past three years and are very happy to expand our mission alongside AXA IM - Real Assets, whose extensive network and local presence in most European countries gives us the opportunity to strengthen our leading position in the European market for life science and lab offices. We are delighted with this partnership and look forward to a successful journey together," Michel Leemhuis, Kadans Science Partner CEO.